Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcome

Pharmacoepidemiology and Drug Safety

Volumn 24, Issue 4, 2015, Pages 353-360

  Wacker, Evelin ^a   Navarro, Ana ^a   Meister, Reinhard ^b   Padberg, Stephanie ^a   Weber Schoendorfer, Corinna ^a   Schaefer, Christof ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b BEUTH UNIVERSITY OF APPLIED SCIENCES   (Germany)

Author keywords

Comparison cohort; Drug safety; Observational cohort study; Pharmacoepidemiology; Pregnancy; Prospective

Indexed keywords

AMOXICILLIN; BUDESONIDE; CETIRIZINE; CITALOPRAM; CLOTRIMAZOLE; CONTRACEPTIVE AGENT; DIMENHYDRINATE; HERBACEOUS AGENT; HOMEOPATHIC AGENT; LEVOTHYROXINE; METOPROLOL; PARACETAMOL; PAROXETINE; VACCINE; VENLAFAXINE; XYLOMETAZOLINE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BIRTH DEFECT; BIRTH WEIGHT; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FETOTOXICITY; FETUS; GESTATIONAL AGE; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MATERNAL ATTITUDE; OBSERVATIONAL STUDY; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING; SPONTANEOUS ABORTION; STILLBIRTH; TERATOGENESIS; TERATOLOGY; ABNORMALITIES, DRUG-INDUCED; ABORTION, SPONTANEOUS; INDUCED ABORTION; MALE; NEWBORN; PREGNANCY; PREMATURE BIRTH; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

ABNORMALITIES, DRUG-INDUCED; ABORTION, INDUCED; ABORTION, SPONTANEOUS; ADULT; BIRTH WEIGHT; COHORT STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; MALE; OBSERVATIONAL STUDIES AS TOPIC; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84925965725     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3744     Document Type: Article

References (21)

1. Lupattelli A, Spigset O, Twigg MJ, et al. Medication use in pregnancy: a cross-sectional, multinational web-based study. BMJ Open 2014; 4(2): e004365. doi: 10.1136/bmjopen-2013-004365.
2. Chambers C. The role of teratology information services in screening for teratogenic exposures: challenges and opportunities. Am J Med Genet C Semin Med Genet 2011; 157C(3): 195-200. doi:10.1002/ajmg.c.30303.
3. Schaefer C. Drug safety in pregnancy: utopia or achievable prospect? Risk information, risk research and advocacy in Teratology Information Services. Congenit Anom (Kyoto) 2011; 51(1): 6-11. doi:10.1111/j.1741-4520.2010.00308.x.
4. Rochon PA, Gurwitz JH, Sykora K, et al. Reader's guide to critical appraisal of cohort studies: 1 Role and design. BMJ 2005; 330(7496): 895-7. doi:10.1136/bmj.330.7496.895.
5. Oppermann M, Fritzsche J, Weber-Schoendorfer C, et al. A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine 2012; 30(30): 4445-52. doi:10.1016/j.vaccine.2012.04.081.
6. Weber-Schoendorfer C, Hoeltzenbein M, Wacker E, et al. No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study. Rheumatology (Oxford) 2014; 53(4): 757-63. doi:10.1093/rheumatology/ket390.
7. Hoeltzenbein M, Weber-Schoendorfer C, Borisch C, et al. Pregnancy outcome after paternal exposure to azathioprine/6-mercaptopurine. Reprod Toxicol 2012; 34(3): 364-9. doi:10.1016/j.reprotox.2012.05.001.
8. Panchaud A, Csajka C, Merlob P, et al. Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study. J Clin Pharmacol 2012; 52(12): 1844-51. doi:10.1177/0091270011429566.
9. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370(9596): 1453-7. doi:10.1016/S0140-6736(07)61602-X.
10. Schaefer C, Ornoy A, Clementi M, et al. Using observational cohort data for studying drug effects on pregnancy outcome-methodological considerations. Reprod Toxicol 2008; 26(1): 36-41. doi:10.1016/j.reprotox.2008.05.064.
11. Padberg S, Wacker E, Meister R, et al. Pregnancy outcome after first trimester exposure to fluoroquinolones: an observational cohort study. Antimicrob Agents Chemother 2014; 58(8): 4392-8. doi: 10.1128/AAC.02413-14.
12. EUROCAT Guide 1.3 and reference documents-instructions for the registration and surveillance of congenital anomalies. EUROCAT Central Registry, Newtownabbey; September 2005. Available at: http://www.eurocat-network.eu/content/EUROCAT-Guide-1.3.pdf (accessed 27 June 2014)
13. Rasmussen SA, Olney RS, Holmes LB, et al. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 2003; 67(3): 193-201. doi:10.1002/bdra.10012.
14. Merks JH, van Karnebeek CD, Caron HN, et al. Phenotypic abnormalities: terminology and classification. Am J Med Genet A 2003; 123A(3): 211-30. doi:10.1002/ajmg.a.20249.
15. D'Agostino RB, Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17(19): 2265-81.
16. McCaffrey DF, Ridgeway G, Morral AR. Propensity score estimation with boosted regression for evaluating causal effects in observational studies. Psychol Methods 2004; 9(4): 403-25. doi:10.1037/1082-989X.9.4.403.
17. Meister R, Schaefer C. Statistical methods for estimating the probability of spontaneous abortion in observational studies-analyzing pregnancies exposed to coumarin derivatives. Reprod Toxicol 2008; 26(1): 31-5. doi:10.1016/j.reprotox.2008.06.006.
18. Voigt M, Rochow N, Hesse V, et al. Short communication about percentile values of body measures of newborn babies. Z Geburtshilfe Neonatol 2010; 214(1): 24-9. doi:10.1055/s-0029-1241833.
19. Little RJA, Rubin DB. Statistical Analysis with Missing Data (2nd edn). John Wiley & Sons: New York, NY, 2002.
20. Rubin DB. Multiple imputation for nonresponse in surveys. Wiley-Interscience: New York, NY, 2004.
21. Sedgh G, Singh S, Henshaw SK, et al. Legal abortion worldwide in 2008: levels and recent trends. Perspect Sex Reprod Health 2011; 43(3): 188-98. doi:10.1363/4318811.